-
Published 2/27/2025
Ibemere SO, Barnhart H, Myers J, Miller J, Osunkwo I, Bosworth HB, Freiermuth CE, Hughes R, Kavanagh PL, Paice JA, Paxton J, Pierce A, Runyon MS, Strouse JJ, Veeramreddy P, Wilkerson RG, Tanabe P. Impact of Individualized Versus Weight-Based Pain Protocols on Patient Satisfaction for Patients With Sickle Cell Disease Experiencing a Vaso-Occlusive Episode. J Emerg Nurs. 2025 Feb 27. PMID: 40019423.
-
Published 10/17/2024
Kavanagh PL, Strouse JJ, Paice JA, Ibemere SO, Tanabe P. Development of a Calculator to Determine Individualized Opioid Doses for Treatment of Vaso-Occlusive Episodes for Sickle Cell Disease in the Emergency Department. Jt Comm J Qual Patient Saf. 2025 Jan; 51(1):74-79. PMID: 39581832.
-
Published 9/20/2024
Blakey AO, Amaro CM, Eilenberg JS, Brochier A, Kavanagh PL, Garg A, Drainoni ML, Long K. Characterizing medical decision-making in sickle cell disease during childhood: Qualitative perspectives of caregivers. Pediatr Blood Cancer. 2024 Dec; 71(12):e31307. PMID: 39302737.
-
Published 8/21/2024
Knisely MR, Barnhart HX, Ibemere SO, Kavanagh P, Paice JA, Strouse JJ, Tanabe PJ. Comparison of Measures of Pain Intensity During Sickle Cell Disease Vaso-Occlusive Episodes. J Pain. 2024 Dec; 25(12):104658. PMID: 39154808.
-
Published 7/15/2024
Rushing M, Horiuchi S, Zhou M, Kavanagh PL, Reeves SL, Snyder A, Paulukonis S. Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics. Pediatr Blood Cancer. 2024 Oct; 71(10):e31188. PMID: 39010280.